APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rifaximin Industry Growth and Trends Forecast to 2032

22 December 202593 pages

Choose your research edition.

Industry ResearchRifaximin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Rifaximin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Rifaximin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rifaximin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rifaximin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifaximin include Texas Pharmaceuticals, STERIS PHARMA, Soigner Pharma, Salix Pharmaceuticals and Cassopeia Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rifaximin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rifaximin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rifaximin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rifaximin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rifaximin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rifaximin Market by Company

Texas Pharmaceuticals

STERIS PHARMA

Soigner Pharma

Salix Pharmaceuticals

Cassopeia Pharmaceuticals

Rifaximin Segment by Type

200 mg Tablets

550 mg Tablets

Rifaximin Segment by Application

Hospital

Drug store

Rifaximin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifaximin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rifaximin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 200 mg Tablets Table 2. Major Company of 550 mg Tablets Table 3. Global Rifaximin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rifaximin Sales by Type (2021-2026) & (k units) Table 5. Global Rifaximin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rifaximin Sales Market Share in Value by Type (2021-2026) Table 8. Global Rifaximin Price by Type (2021-2026) & (US$/unit) Table 9. Global Rifaximin Sales by Type (2027-2032) & (k units) Table 10. Global Rifaximin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rifaximin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rifaximin Sales Market Share in Value by Type (2027-2032) Table 13. Global Rifaximin Price by Type (2027-2032) & (US$/unit) Table 14. North America Rifaximin Sales by Type (2021-2026) & (k units) Table 15. North America Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rifaximin Sales by Type (2021-2026) & (k units) Table 17. Europe Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rifaximin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rifaximin Sales by Type (2021-2026) & (k units) Table 21. Latin America Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rifaximin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Rifaximin Sales by Type (2021-2026) & (US$ Million) Table 24. Rifaximin Industry Trends Table 25. Rifaximin Industry Drivers Table 26. Rifaximin Industry Opportunities and Challenges Table 27. Rifaximin Industry Restraints Table 28. Global Rifaximin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rifaximin Revenue Market Share by Company (2021-2026) Table 30. Global Rifaximin Sales by Company (2021-2026) & (k units) Table 31. Global Rifaximin Sales Share by Company (2021-2026) Table 32. Global Rifaximin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Rifaximin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rifaximin Major Company Production Sites and Headquarters Table 35. Global Rifaximin Company, Product Type & Application Table 36. Global Rifaximin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rifaximin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rifaximin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rifaximin Sales by Region (2021-2026) & (k units) Table 41. Global Rifaximin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rifaximin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rifaximin Sales Market Share in Value by Region (2021-2026) Table 44. Global Rifaximin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Rifaximin Sales by Region (2027-2032) & (k units) Table 46. Global Rifaximin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rifaximin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rifaximin Sales Market Share in Value by Region (2027-2032) Table 49. Global Rifaximin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Rifaximin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rifaximin Sales by Application (2021-2026) & (k units) Table 52. Global Rifaximin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rifaximin Sales Market Share in Value by Application (2021-2026) Table 55. Global Rifaximin Price by Application (2021-2026) & (US$/unit) Table 56. Global Rifaximin Sales by Application (2027-2032) & (k units) Table 57. Global Rifaximin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rifaximin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rifaximin Sales Market Share in Value by Application (2027-2032) Table 60. Global Rifaximin Price by Application (2027-2032) & (US$/unit) Table 61. North America Rifaximin Sales by Application (2021-2026) & (k units) Table 62. North America Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rifaximin Sales by Application (2021-2026) & (k units) Table 64. Europe Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rifaximin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rifaximin Sales by Application (2021-2026) & (k units) Table 68. Latin America Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rifaximin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Rifaximin Sales by Application (2021-2026) & (US$ Million) Table 71. Texas Pharmaceuticals Company Information Table 72. Texas Pharmaceuticals Business Overview Table 73. Texas Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Texas Pharmaceuticals Rifaximin Product Portfolio Table 75. Texas Pharmaceuticals Recent Development Table 76. STERIS PHARMA Company Information Table 77. STERIS PHARMA Business Overview Table 78. STERIS PHARMA Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. STERIS PHARMA Rifaximin Product Portfolio Table 80. STERIS PHARMA Recent Development Table 81. Soigner Pharma Company Information Table 82. Soigner Pharma Business Overview Table 83. Soigner Pharma Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Soigner Pharma Rifaximin Product Portfolio Table 85. Soigner Pharma Recent Development Table 86. Salix Pharmaceuticals Company Information Table 87. Salix Pharmaceuticals Business Overview Table 88. Salix Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Salix Pharmaceuticals Rifaximin Product Portfolio Table 90. Salix Pharmaceuticals Recent Development Table 91. Cassopeia Pharmaceuticals Company Information Table 92. Cassopeia Pharmaceuticals Business Overview Table 93. Cassopeia Pharmaceuticals Rifaximin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Cassopeia Pharmaceuticals Rifaximin Product Portfolio Table 95. Cassopeia Pharmaceuticals Recent Development Table 96. North America Rifaximin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Rifaximin Sales by Country (2021-2026) & (k units) Table 98. North America Rifaximin Sales Market Share by Country (2021-2026) Table 99. North America Rifaximin Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Rifaximin Sales Market Share Forecast by Country (2027-2032) Table 101. North America Rifaximin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Rifaximin Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Rifaximin Market Share by Country (2021-2026) Table 104. North America Rifaximin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Rifaximin Market Share Forecast by Country (2027-2032) Table 106. Europe Rifaximin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Rifaximin Sales by Country (2021-2026) & (k units) Table 108. Europe Rifaximin Sales Market Share by Country (2021-2026) Table 109. Europe Rifaximin Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Rifaximin Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Rifaximin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Rifaximin Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Rifaximin Market Share by Country (2021-2026) Table 114. Europe Rifaximin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Rifaximin Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Rifaximin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Rifaximin Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Rifaximin Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Rifaximin Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Rifaximin Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Rifaximin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Rifaximin Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Rifaximin Market Share by Country (2021-2026) Table 124. Asia-Pacific Rifaximin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Rifaximin Market Share Forecast by Country (2027-2032) Table 126. Latin America Rifaximin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Rifaximin Sales by Country (2021-2026) & (k units) Table 128. Latin America Rifaximin Sales Market Share by Country (2021-2026) Table 129. Latin America Rifaximin Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Rifaximin Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Rifaximin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Rifaximin Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Rifaximin Market Share by Country (2021-2026) Table 134. Latin America Rifaximin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Rifaximin Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Rifaximin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Rifaximin Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Rifaximin Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Rifaximin Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Rifaximin Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Rifaximin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Rifaximin Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Rifaximin Market Share by Country (2021-2026) Table 144. Middle East and Africa Rifaximin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Rifaximin Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Rifaximin Distributors List Table 149. Rifaximin Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Rifaximin Image Figure 2. Global Rifaximin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifaximin Sales (2021-2032) & (k units) Figure 5. 200 mg Tablets Image Figure 6. Global 200 mg Tablets Sales YoY Growth (2021-2032) & (k units) Figure 7. 550 mg Tablets Image Figure 8. Global 550 mg Tablets Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Rifaximin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rifaximin Market Share by Type 2025 VS 2032 Figure 11. North America Rifaximin Sales Market Share in Volume by Type in 2025 Figure 12. North America Rifaximin Sales Market Share in Value by Type in 2025 Figure 13. Europe Rifaximin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rifaximin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rifaximin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rifaximin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rifaximin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rifaximin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rifaximin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rifaximin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rifaximin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Drug store Image Figure 26. Global Drug store Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Rifaximin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Rifaximin Market Share by Application 2025 VS 2032 Figure 29. North America Rifaximin Sales Market Share in Volume by Application in 2025 Figure 30. North America Rifaximin Sales Market Share in Value by Application in 2025 Figure 31. Europe Rifaximin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Rifaximin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Rifaximin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Rifaximin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Rifaximin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Rifaximin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Rifaximin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Rifaximin Sales Market Share in Value by Application in 2025 Figure 39. North America Rifaximin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Rifaximin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Rifaximin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Rifaximin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Rifaximin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Rifaximin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rifaximin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Rifaximin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Rifaximin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Rifaximin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rifaximin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Rifaximin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Rifaximin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Rifaximin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rifaximin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Rifaximin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Rifaximin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Rifaximin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rifaximin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Rifaximin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Rifaximin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Rifaximin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 200 mg Tablets
  • 550 mg Tablets
Applications
  • Hospital
  • Drug store
Companies covered
  • Texas Pharmaceuticals
  • STERIS PHARMA
  • Soigner Pharma
  • Salix Pharmaceuticals
  • Cassopeia Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rifaximin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rifaximin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rifaximin Market by Type
  6. 1.3.1 200 mg Tablets
  7. 1.3.2 550 mg Tablets
  8. 1.4 Global Rifaximin Market Size by Type
  9. 1.4.1 Global Rifaximin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rifaximin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rifaximin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rifaximin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rifaximin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rifaximin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rifaximin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rifaximin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rifaximin Industry Trends
  2. 2.2 Rifaximin Industry Drivers
  3. 2.3 Rifaximin Industry Opportunities and Challenges
  4. 2.4 Rifaximin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rifaximin Revenue (2021-2026)
  2. 3.2 Global Top Players by Rifaximin Sales (2021-2026)
  3. 3.3 Global Top Players by Rifaximin Price (2021-2026)
  4. 3.4 Global Rifaximin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifaximin Major Company Production Sites & Headquarters
  6. 3.6 Global Rifaximin Company, Product Type & Application
  7. 3.7 Global Rifaximin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifaximin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifaximin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifaximin Tier 1, Tier 2, and Tier 3
4 Rifaximin Regional Status and Outlook
  1. 4.1 Global Rifaximin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rifaximin Historic Market Size by Region
  3. 4.2.1 Global Rifaximin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rifaximin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rifaximin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rifaximin Forecasted Market Size by Region
  7. 4.3.1 Global Rifaximin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rifaximin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rifaximin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rifaximin by Application
  1. 5.1 Rifaximin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Rifaximin Market Size by Application
  5. 5.2.1 Global Rifaximin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Rifaximin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Rifaximin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Rifaximin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Rifaximin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Rifaximin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Rifaximin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Rifaximin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Texas Pharmaceuticals
  2. 6.1.1 Texas Pharmaceuticals Company Information
  3. 6.1.2 Texas Pharmaceuticals Business Overview
  4. 6.1.3 Texas Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Texas Pharmaceuticals Rifaximin Product Portfolio
  6. 6.1.5 Texas Pharmaceuticals Recent Developments
  7. 6.2 STERIS PHARMA
  8. 6.2.1 STERIS PHARMA Company Information
  9. 6.2.2 STERIS PHARMA Business Overview
  10. 6.2.3 STERIS PHARMA Rifaximin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 STERIS PHARMA Rifaximin Product Portfolio
  12. 6.2.5 STERIS PHARMA Recent Developments
  13. 6.3 Soigner Pharma
  14. 6.3.1 Soigner Pharma Company Information
  15. 6.3.2 Soigner Pharma Business Overview
  16. 6.3.3 Soigner Pharma Rifaximin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Soigner Pharma Rifaximin Product Portfolio
  18. 6.3.5 Soigner Pharma Recent Developments
  19. 6.4 Salix Pharmaceuticals
  20. 6.4.1 Salix Pharmaceuticals Company Information
  21. 6.4.2 Salix Pharmaceuticals Business Overview
  22. 6.4.3 Salix Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Salix Pharmaceuticals Rifaximin Product Portfolio
  24. 6.4.5 Salix Pharmaceuticals Recent Developments
  25. 6.5 Cassopeia Pharmaceuticals
  26. 6.5.1 Cassopeia Pharmaceuticals Company Information
  27. 6.5.2 Cassopeia Pharmaceuticals Business Overview
  28. 6.5.3 Cassopeia Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cassopeia Pharmaceuticals Rifaximin Product Portfolio
  30. 6.5.5 Cassopeia Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Rifaximin Sales by Country
  2. 7.1.1 North America Rifaximin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rifaximin Sales by Country (2021-2026)
  4. 7.1.3 North America Rifaximin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rifaximin Market Size by Country
  6. 7.2.1 North America Rifaximin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rifaximin Market Size by Country (2021-2026)
  8. 7.2.3 North America Rifaximin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rifaximin Sales by Country
  2. 8.1.1 Europe Rifaximin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rifaximin Sales by Country (2021-2026)
  4. 8.1.3 Europe Rifaximin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rifaximin Market Size by Country
  6. 8.2.1 Europe Rifaximin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rifaximin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rifaximin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rifaximin Sales by Country
  2. 9.1.1 Asia-Pacific Rifaximin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rifaximin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rifaximin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rifaximin Market Size by Country
  6. 9.2.1 Asia-Pacific Rifaximin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rifaximin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rifaximin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rifaximin Sales by Country
  2. 10.1.1 South America Rifaximin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rifaximin Sales by Country (2021-2026)
  4. 10.1.3 South America Rifaximin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rifaximin Market Size by Country
  6. 10.2.1 South America Rifaximin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rifaximin Market Size by Country (2021-2026)
  8. 10.2.3 South America Rifaximin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rifaximin Sales by Country
  2. 11.1.1 Middle East and Africa Rifaximin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rifaximin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rifaximin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rifaximin Market Size by Country
  6. 11.2.1 Middle East and Africa Rifaximin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rifaximin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rifaximin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rifaximin Value Chain Analysis
  2. 12.1.1 Rifaximin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rifaximin Production Mode & Process
  7. 12.2 Rifaximin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rifaximin Distributors
  10. 12.2.3 Rifaximin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst